miconazole has been researched along with Sporotrichosis in 6 studies
Miconazole: An imidazole antifungal agent that is used topically and by intravenous infusion.
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole : A member of the class of imidazoles that is 1-(2,4-dichlorophenyl)-2-(imidazol-1-yl)ethanol in which the hydroxyl hydrogen is replaced by a 2,4-dichlorobenzyl group.
miconazole : A racemate composed of equimolar amounts of (R)- and (S)-miconazole. Used (as its nitrate salt) to treat skin infections such as athlete's foot, jock itch, ringworm and other fungal skin infections. It inhibits the synthesis of ergosterol, a critical component of fungal cell membranes.
Sporotrichosis: The commonest and least serious of the deep mycoses, characterized by nodular lesions of the cutaneous and subcutaneous tissues. It is caused by inhalation of contaminated dust or by infection of a wound with SPOROTHRIX.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intravenous miconazole, an investigational, broad-spectrum, antifungal imidazole drug, was clinically effective when used for the first time in a patient with life-threatening sporotrichosis." | 7.65 | Pulmonary sporotrichosis: Treatment with miconazole. ( Archer, G; Rohwedder, JJ, 1976) |
| "Intravenous miconazole, an investigational, broad-spectrum, antifungal imidazole drug, was clinically effective when used for the first time in a patient with life-threatening sporotrichosis." | 3.65 | Pulmonary sporotrichosis: Treatment with miconazole. ( Archer, G; Rohwedder, JJ, 1976) |
| "The deep mycoses are increasing in importance both as opportunistic infections and from exposure in geographically defined areas." | 2.37 | Cutaneous and mucosal manifestations of the deep mycotic infections. ( Meyer, RD, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisher, JF | 1 |
| Duma, RJ | 1 |
| Markowitz, SM | 1 |
| Shadomy, S | 1 |
| Espinel-Ingroff, A | 1 |
| Chew, WH | 1 |
| Beardmore, GL | 1 |
| Utz, JP | 1 |
| Mohr, JA | 1 |
| Griffiths, W | 1 |
| Long, H | 1 |
| Rohwedder, JJ | 1 |
| Archer, G | 1 |
| Meyer, RD | 1 |
1 review available for miconazole and Sporotrichosis
| Article | Year |
|---|---|
Cutaneous and mucosal manifestations of the deep mycotic infections.
Topics: Amphotericin B; Aspergillosis; Blastomycosis; Candidiasis; Candidiasis, Cutaneous; Coccidioidomycosi | 1986 |
5 other studies available for miconazole and Sporotrichosis
| Article | Year |
|---|---|
Therapeutic failures with miconazole.
Topics: Adult; Aspergillosis; Aspergillus fumigatus; Child; Cryptococcus neoformans; Humans; Imidazoles; Mal | 1978 |
Recalcitrant sporotrichosis: a report of a patient treated with various therapies including oral miconazole and 5-fluorocytosine.
Topics: Administration, Oral; Adult; Amphotericin B; Cautery; Cryosurgery; Curettage; Cytosine; Dermatomycos | 1979 |
The current status of chemotherapeutic agents for the systemic mycoses.
Topics: Amphotericin B; Antifungal Agents; Blastomycosis; Clotrimazole; Flucytosine; Humans; Miconazole; Myc | 1977 |
Pulmonary sporotrichosis in Oklahoma in susceptibilities in vitro.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Follow-Up Studies; Humans; In Vitro Techniques; Lu | 1979 |
Pulmonary sporotrichosis: Treatment with miconazole.
Topics: Amphotericin B; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Therapy, Combinat | 1976 |